Janux Therapeutics, Inc.
USD16.26
+0.21 (+1.31%)
CEO
David Alan Campbell
IPO Date
2021-06-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.97
Prev. Close
$16.05
Day Low
$15.94
Day High
$16.30
52W Low
$12.12
52W High
$35.34
Market Cap
$0.99B
Volume
0.67M
| 7,000 |
| $4.21 |
| 12 Jun 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | Acquired | 5,500 | $0.00 |
| 12 Jun 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | Acquired | 15,500 | $13.66 |
| 12 Jun 2026 | Simson Jake | director | A-Award | Acquired | 5,500 | $0.00 |
| 12 Jun 2026 | Simson Jake | director | A-Award | Acquired | 15,500 | $13.66 |
| 12 Jun 2026 | Kung Winston | director | A-Award | Acquired | 5,500 | $0.00 |
| 12 Jun 2026 | Kung Winston | director | A-Award | Acquired | 15,500 | $13.66 |
| 12 Jun 2026 | Hernday Natasha | director | A-Award | Acquired | 5,500 | $0.00 |
| 12 Jun 2026 | Hernday Natasha | director | A-Award | Acquired | 15,500 | $13.66 |